Trained over 130 clinical research students...Contributed over 500 nurses to the healthcare industry...India’s largest Site Management Organization...Partnered with industry to facilitate over 200 clinical trials...Pioneers of Telemedicine in India.

Regenerative Medicine and Translational Research

font decreasefont increase SocialTwist Tell-a-Friend

TraditionalStrategic Focus

 

The center aims to carry out research in the areas of cell and molecular biology. A major thrust area will be Stem Cell Research and Clinical Applications. Another focus of the center will be Molecular Diagnostics.

 

Cell & Molecular Biology Research Center (CMBRC):

 

Constructed in 4000 sq ft of space, with 2000 sq ft converted to a Class 10,000 cell culture facility. Along with this the center also has a Committee Room cum Library and 2 large labs for Cell and Molecular biology research.
The center aims to undertake the following activities-

    1. Stem cell research
    2. Training Programs
    3. Clinical Trials involving Stem Cells followed by therapy in promising areas
    4. Supplying stem cells to outside institutes for clinical trials /therapy
    5. Diagnostics – Basic and applied
Our Team

Dr. Ashok Khar, Director
Dr. Preeti Kapoor, Senior Scientist and Group Leader
Research Assistants

 

Potential for Collaboration

  • Open to collaborations with top institutions in the country and outside India.
  • Submission of joint project proposals for financial support from Government agencies is another agenda.

Projects in the pipeline:

 

A randomized controlled trial using autologous bone marrow derived mesenchymal stem cells for the treatment of cerebral palsy


Principal Investigator: Prof. Veena Kalra

Senior Consultant, Paediatric Neurology
Indraprastha Apollo Hospitals, New Delhi
Project duration: 2 years
Co-investigator:
Dr. Koninika Ray
Scientific Consultant, AHERF, New Delhi

 

Facts on Cerebral Palsy:

- Nonprogressive neuromotor disorder

- Caused by lesions or anomalies in the developing brain

- During prenatal, perinatal and postnatal periods

Typical Symptoms:

Abnormality of motor/tone, seizures, hearing loss, difficulty in speaking, blindness, lack of co-ordination and/or mental retardation

Broadly divided into:

Spastic, Ataxic, Athetoid/diskinetic and Mixed

Incidence:

2-2.5/1000 live births

 

Objective

  • To carry out a randomized controlled trial using autologous bone marrow derived mesenchymal stem cells for therapy in 60 children diagnosed with cerebral palsy
  • To study the effect of Granulocyte – Colony Stimulating Factor administered concurrent with autologous mesenchymal stem cell transfusion on outcome parameters in children with cerebral palsy
 
Achieving critical yet most effective, affordable and far reaching healthcare capabilities through Research & Education. Full time and part time Clinical Research Courses successfully running at different sites.